NCT03878095 2026-04-08Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant TumorsNational Cancer Institute (NCI)Phase 2 Active not recruiting24 enrolled 12 charts
NCT04762602 2026-03-27A Study of HMPL-306 in Advanced Solid Tumors With IDH MutationsHutchmedPhase 1 Terminated42 enrolled 26 charts
NCT04003636 2026-03-24KEYNOTE-966Merck Sharp & Dohme LLCPhase 3 Completed1,069 enrolled 19 charts 2 FDA